Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mylan Joins Firms Facing DOJ Probe On Price Hikes; Senate Plans Industry-Free Hearing

This article was originally published in The Pink Sheet Daily

Executive Summary

Senate Special Aging Committee hearing Wednesday to focus on price spikes in off-patent drugs without testimony from drug makers.


Related Content

Generic Industry Hit With Avalanche Of Price Fixing Suits
Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors
Could Drug Price Spikes Spur ANDA Priority Reviews?
Gilead's Pricing Strategy Faces New Opposition Tactics: Patent, Antitrust Suit
Senate's Bipartisan Rx Pricing Probe Seeks Documents Regarding FDA Regs
PhRMA Takes Aim At Valeant In Defense Of Drug Pricing By ‘Innovative’ Firms


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts